PARVOLEX
PARVOLEX
Discontinued
DIN Number
02181460
Drug Class
Human
Market Date
Dec 31, 1996
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02181460
AIG Number0100024001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
R05CB01 ACETYLCYSTEINE
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
,
Inhalation
,
Intravenous
AHFS Classification91:04.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
ACETYLCYSTEINEActive
Strength: 200 MG / ML
Monograph: ACETYLCYSTEINE